GOLD SALT-INDUCED CHOLESTASIS

被引：22

作者：

PESSAYRE, D ^{[1
]}

FELDMANN, G ^{[1
]}

DEGOTT, C ^{[1
]}

ULMANN, A ^{[1
]}

ROGER, W ^{[1
]}

ERLINGER, S ^{[1
]}

BENHAMOU, JP ^{[1
]}

机构：

[1] FAC MED XAVIER BICHAT,HISTOL EMBRYOL & CYTOGENET LAB,PARIS,FRANCE

来源：

DIGESTION | 1979年 / 19卷 / 01期

关键词：

Cholestasis; Drug toxicity; Electron microscopy; Gold salt; Hepatitis; Liver function test;

D O I：

10.1159/000198323

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

The authors report the case of a patient with transient intrahepatic cholestasis following the administration of a soluble gold salt, sodium aurothiopropanol sulfonate. Other manifestations of intolerance to gold salts included exfoliative dermatitis and eosinophilia. © 1979 S. Karger AG, Basel.

引用

页码：56 / 64

页数：9

共 19 条

[1]

Brown H, 1926, J PHARMACOL EXP THER, V28, P141

[2]

DUBIN M, 1978, GASTROENTEROLOGY, V75, P450

[3]

ERLINGER S, 1978, LANCET, V1, P533

[4] INTERACTION OF GOLD AND PENICILLAMINE [J].

EYRING, EJ ;

ENGLEMAN, EP .

ARTHRITIS AND RHEUMATISM, 1963, 6 (03) :216-&

[5] HEPATIC TOXICITY ASSOCIATED WITH GOLD THERAPY [J].

FAVREAU, M ;

TANNENBAUM, H ;

LOUGH, J .

ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) :717-719

[6]

FORESTIER J, 1961, Rhumatologie, V13, P69

[7]

GHISOLFI J, 1972, ARCH FR PEDIATR, V29, P1097

[8]

GROSBY GJV, 1936, LANCET, V1, P1463

[9]

Hartfall SJ, 1937, LANCET, V2, P838

[10]

HARVEY SC, 1975, PHARMACOL BASIS THER, P924

← 1 2 →